Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
4856 | 1643 | 35.0 | 82% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
869 | 10864 | LIPODYSTROPHY//HIV ASSOCIATED NEPHROPATHY//LIPOATROPHY |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | HIV ASSOCIATED NEPHROPATHY | Author keyword | 105 | 77% | 4% | 71 |
2 | TENOFOVIR | Author keyword | 51 | 26% | 10% | 171 |
3 | HIVAN | Author keyword | 30 | 68% | 2% | 26 |
4 | HIV ASSOCIATED NEPHROPATHY HIVAN | Author keyword | 21 | 90% | 1% | 9 |
5 | HIV NEPHROPATHY | Author keyword | 14 | 57% | 1% | 17 |
6 | HUMAN IMMUNODEFICIENCY VIRUS ASSOCIATED NEPHROPATHY | Author keyword | 13 | 71% | 1% | 10 |
7 | AIDS ASSOCIATED NEPHROPATHY | Author keyword | 12 | 86% | 0% | 6 |
8 | HIV 1 ASSOCIATED NEPHROPATHY | Author keyword | 6 | 80% | 0% | 4 |
9 | INDINAVIR | Author keyword | 5 | 13% | 2% | 40 |
10 | COMMUNITY CARE | Address | 5 | 38% | 1% | 11 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | HIV 1 ASSOCIATED NEPHROPATHY | 124 | 90% | 3% | 54 |
2 | PATIENTS RECEIVING TENOFOVIR | 44 | 100% | 1% | 16 |
3 | DISOPROXIL FUMARATE | 41 | 30% | 7% | 115 |
4 | HIV ASSOCIATED NEPHROPATHY | 35 | 31% | 6% | 93 |
5 | FANCONI SYNDROME | 33 | 30% | 6% | 93 |
6 | DOSING MODIFICATIONS | 19 | 80% | 1% | 12 |
7 | CALCULATED CREATININE CLEARANCE | 14 | 100% | 0% | 7 |
8 | PATIENTS RECEIVING DIALYSIS | 13 | 80% | 0% | 8 |
9 | TENOFOVIR RELATED NEPHROTOXICITY | 13 | 80% | 0% | 8 |
10 | RECEIVING TENOFOVIR | 10 | 73% | 0% | 8 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Tenofovir-Associated Kidney Toxicity in HIV-Infected Patients: A Review of the Evidence | 2011 | 82 | 57 | 61% |
Guidelines for the management of chronic kidney disease in HIV-infected patients: Recommendations of the HIV Medicine Association of the Infectious Diseases Society of America | 2005 | 332 | 167 | 65% |
Tenofovir-associated acute and chronic kidney disease: A case of multiple drug interactions | 2006 | 161 | 18 | 67% |
Antiretrovirals and the kidney in current clinical practice: renal pharmacokinetics, alterations of renal function and renal toxicity | 2014 | 9 | 90 | 57% |
Update on tenofovir toxicity in the kidney | 2013 | 15 | 98 | 76% |
Renal toxicity associated with tenofovir use | 2010 | 55 | 62 | 84% |
HIV-associated renal diseases and highly active antiretroviral therapy-induced nephropathy | 2006 | 90 | 73 | 79% |
The changing epidemiology of HIV-related chronic kidney disease in the era of antiretroviral therapy | 2014 | 4 | 47 | 85% |
Tenofovir Effect on the Kidneys of HIV-Infected Patients: A Double-Edged Sword? | 2013 | 10 | 65 | 77% |
Renal transplantation in HIV-infected patients: 2010 update | 2011 | 21 | 87 | 75% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | COMMUNITY CARE | 5 | 38% | 0.7% | 11 |
2 | HOSP ST JAUME DE OLOT | 4 | 75% | 0.2% | 3 |
3 | INTERNAL MED CLIN IMMUNOL UNIT | 4 | 75% | 0.2% | 3 |
4 | RENAL SCI | 4 | 46% | 0.4% | 6 |
5 | INFECT DIS IMMUNOPATHOL UNIT | 3 | 100% | 0.2% | 3 |
6 | CLIN INFECT DIS HOSP HYG | 2 | 67% | 0.1% | 2 |
7 | MED INTERNE INFECTIOL | 2 | 67% | 0.1% | 2 |
8 | SURG ONCOL LIVER TRANSPLANTAT | 2 | 67% | 0.1% | 2 |
9 | DIAGNOSIS VIRAL DIS | 1 | 50% | 0.1% | 2 |
10 | HOSP BELLVITGE IDIBELL | 1 | 50% | 0.1% | 2 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000134712 | CAS 396 01 0//CRYSTALLURIA//CALCULI ANALYSIS |
2 | 0.0000093651 | HIV MOL GRP//MED INT MED INFECT DIS//BODY COMPOSIT ANAL |
3 | 0.0000083031 | APOL1//APOLIPOPROTEIN L1//APOLIPOPROTEIN L |
4 | 0.0000072653 | ATAZANAVIR//RITONAVIR//LOPINAVIR |
5 | 0.0000065477 | HIV HCV CO INFECTION//HIV HCV COINFECTION//COINFECTION |
6 | 0.0000064820 | ROYAL FREE HIV MED//CD4 CELL COUNT//X BICHAT MED |
7 | 0.0000062646 | HEPATITIS B VIRUS ASSOCIATED GLOMERULONEPHRITIS//HBV ASSOCIATED NEPHROPATHY//HEPATITIS B SURFACE ANTIGENEMIA |
8 | 0.0000047391 | LIPODYSTROPHY//LIPOATROPHY//PROGRAM NUTR METAB |
9 | 0.0000045073 | MITOCHONDRIAL TOXICITY//DISTAL SENSORY POLYNEUROPATHY//ANTIRETROVIRAL TOXIC NEUROPATHY |
10 | 0.0000044356 | 1200 N STATE ST//ADRENAL RESERVE//ADRENOCORTICAL DYSFUNCTION |